Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


15.05.2017

9 Am J Cardiol
2 Am J Med
1 Ann Intern Med
4 Arterioscler Thromb Vasc Biol
1 BMJ
1 Catheter Cardiovasc Interv
11 Circ Cardiovasc Imaging
7 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
7 Circ Res
7 Circulation
1 Eur Heart J
1 Hypertension
1 Int J Cardiol
10 J Am Coll Cardiol
1 J Mol Cell Cardiol
3 Mayo Clin Proc
1 Mol Cell Biochem
6 N Engl J Med
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. YEOH J, Yudi MB, Andrianopoulos N, Yan BP, et al
    Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry).
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30629.
    PubMed     Text format     Abstract available

  2. CAVUSOGLU E, Kassotis JT, Marmur JD, Banerji MA, et al
    Usefulness of Plasma Tissue Inhibitor of Matrix Metalloproteinase-4 to Predict Death and Myocardial Infarction in Patients With Diabetes Mellitus Referred for Coronary Angiography.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30638.
    PubMed     Text format     Abstract available

  3. SHAMIM S, Tang F, Safley D, Jones P, et al
    Patient Versus Physician Variation in Use of Transradial Percutaneous Coronary Intervention.
    Am J Cardiol. 2017 Mar 30. pii: S0002-9149(17)30343.
    PubMed     Text format     Abstract available

  4. GILI S, D'Ascenzo F, Di Summa R, Conrotto F, et al
    Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30633.
    PubMed     Text format     Abstract available

  5. MCCARTHY CP, van Kimmenade RRJ, Gaggin HK, Simon ML, et al
    Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30636.
    PubMed     Text format     Abstract available

  6. KURAMITSU S, Jinnouchi H, Shinozaki T, Hiromasa T, et al
    Incidence and Long-Term Clinical Impact of Late-Acquired Stent Fracture After Sirolimus-Eluting Stent Implantation in Narrowed Coronary Arteries.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30630.
    PubMed     Text format     Abstract available

  7. DI GIOIA G, Scarsini R, Strisciuglio T, De Biase C, et al
    Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30621.
    PubMed     Text format     Abstract available

  8. KANG SH, Lee CW, Baek S, Lee PH, et al
    Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30632.
    PubMed     Text format     Abstract available

  9. KURTUL A, Acikgoz SK
    Validation of the CHA2DS2-VASc Score in Predicting Coronary Atherosclerotic Burden and In-Hospital Mortality in Patients With Acute Coronary Syndrome.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30637.
    PubMed     Text format     Abstract available


    Am J Med

  10. AL RIFAI M, Patel J, Hung RK, Nasir K, et al
    Higher Fitness Is Strongly Protective in Patients with Family History of Heart Disease: The FIT Project.
    Am J Med. 2017;130:367-371.
    PubMed     Text format     Abstract available

  11. BROWN RA, Shantsila E, Varma C, Lip GY, et al
    Current Understanding of Atherogenesis.
    Am J Med. 2017;130:268-282.
    PubMed     Text format     Abstract available


    Ann Intern Med

  12. WASFY JH, Zigler CM, Choirat C, Wang Y, et al
    Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis.
    Ann Intern Med. 2017;166:324-331.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  13. PRASAD A, Clopton P, Ayers C, Khera A, et al
    Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
    Arterioscler Thromb Vasc Biol. 2017 May 4. pii: ATVBAHA.117.309101.
    PubMed     Text format     Abstract available

  14. MELOCHE J, Lampron MC, Nadeau V, Maltais M, et al
    Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2017 May 4. pii: ATVBAHA.117.309156.
    PubMed     Text format     Abstract available

  15. VAN CAPELLEVEEN JC, Bernelot Moens SJ, Yang X, Kastelein JJP, et al
    Apolipoprotein CIII Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
    Arterioscler Thromb Vasc Biol. 2017 May 4. pii: ATVBAHA.117.309007.
    PubMed     Text format     Abstract available

  16. DOU H, Feher A, Davila AC, Romero MJ, et al
    Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction.
    Arterioscler Thromb Vasc Biol. 2017 May 4. pii: ATVBAHA.117.309430.
    PubMed     Text format     Abstract available


    BMJ

  17. BALLY M, Dendukuri N, Rich B, Nadeau L, et al
    Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.
    BMJ. 2017;357:j1909.
    PubMed     Text format     Abstract available


    Catheter Cardiovasc Interv

  18. ARORA S, Matsushita K, Qamar A, Stacey RB, et al
    Early versus Late Percutaneous Revascularization in Patients Hospitalized with Non ST-Segment Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study.
    Catheter Cardiovasc Interv. 2017 May 12. doi: 10.1002/ccd.27156.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  19. BITTNER DO, Mayrhofer T, Bamberg F, Hallett TR, et al
    Impact of Coronary Calcification on Clinical Management in Patients With Acute Chest Pain.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  20. ROSSI A, Wragg A, Klotz E, Pirro F, et al
    Dynamic Computed Tomography Myocardial Perfusion Imaging: Comparison of Clinical Analysis Methods for the Detection of Vessel-Specific Ischemia.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  21. ABRAM S, Arruda-Olson AM, Scott CG, Pellikka PA, et al
    Frequency, Predictors, and Implications of Abnormal Blood Pressure Responses During Dobutamine Stress Echocardiography.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  22. NAOUM C, Berman DS, Ahmadi A, Blanke P, et al
    Predictive Value of Age- and Sex-Specific Nomograms of Global Plaque Burden on Coronary Computed Tomography Angiography for Major Cardiac Events.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  23. KITKUNGVAN D, Lai D, Zhu H, Roby AE, et al
    Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  24. HUBBARD L, Ziemer B, Lipinski J, Sadeghi B, et al
    Functional Assessment of Coronary Artery Disease Using Whole-Heart Dynamic Computed Tomographic Perfusion.
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available

  25. SINGH P, Emami H, Subramanian S, Maurovich-Horvat P, et al
    Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available

  26. KIM J, Di Franco A, Seoane T, Srinivasan A, et al
    Right Ventricular Dysfunction Impairs Effort Tolerance Independent of Left Ventricular Function Among Patients Undergoing Exercise Stress Myocardial Perfusion Imaging.
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available

  27. PONTONE G, Guaricci AI, Andreini D, Solbiati A, et al
    Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillato
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available

  28. BOM MJ, van der Heijden DJ, Kedhi E, van der Heyden J, et al
    Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes?
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available

  29. QIN X, Riegler J, Tiburcy M, Zhao X, et al
    Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  30. STROM JB, McCabe JM, Waldo SW, Pinto DS, et al
    Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  31. GIACOPPO D, Gargiulo G, Buccheri S, Aruta P, et al
    Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  32. GASIOR P, Cheng Y, Valencia AF, McGregor J, et al
    Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  33. ANDELL P, Karlsson S, Mohammad MA, Gotberg M, et al
    Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  34. PARK DW, Park SJ
    Intravascular Ultrasound-Guided Percutaneous Coronary Intervention for Left Main Disease: Does Procedural Fine-Tuning Make a Relevant Clinical Benefit?
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format    

  35. SOTOMI Y, Onuma Y, Cavalcante R, Ahn JM, et al
    Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus An
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  36. REDFORS B, Genereux P, Witzenbichler B, McAndrew T, et al
    Percutaneous Coronary Intervention of Saphenous Vein Graft.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Qual Outcomes

  37. BURKE JF, Nallamothu BK, Ho PM
    The Review and Editorial Process at Circulation: Cardiovascular Quality and Outcomes: The Worst System, Except for All the Others.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format    


    Circ Res

  38. WATERS DD, Hsue PY
    PCSK9 Inhibition to Reduce Cardiovascular Risk: Tempering Expectations.
    Circ Res. 2017;120:1537-1539.
    PubMed     Text format    

  39. SERPOOSHAN V
    A Multidisciplinary and Multicultural Adventure: From Materials Engineering to Cardiovascular Science.
    Circ Res. 2017;120:1540-1541.
    PubMed     Text format    

  40. WILLERSON JT
    The Texas Heart Institute: Part 2-Working Toward the Next Breakthrough in Cardiovascular Medicine.
    Circ Res. 2017;120:1548-1550.
    PubMed     Text format    

  41. JANSEN F, Nickenig G, Werner N
    Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology.
    Circ Res. 2017;120:1649-1657.
    PubMed     Text format     Abstract available

  42. HAMMADAH M, Al Mheid I, Wilmot K, Ramadan R, et al
    Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.
    Circ Res. 2017;120:1130-1138.
    PubMed     Text format     Abstract available

  43. GEWIRTZ H, Dilsizian V
    Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia.
    Circ Res. 2017;120:1197-1212.
    PubMed     Text format     Abstract available

  44. SHAHRIVARI M, Wise E, Resende MM, Shuster JJ, et al
    Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1beta and IL-6 Related Impairment of Bone Marrow Function.
    Circ Res. 2017 May 10. pii: CIRCRESAHA.116.309947.
    PubMed     Text format     Abstract available


    Circulation

  45. WADHERA RK, Joynt KE
    Insurance and Cardiovascular Health: Time for Evidence to Trump Politics.
    Circulation. 2017 May 4. pii: CIRCULATIONAHA.117.028618.
    PubMed     Text format     Abstract available

  46. WADHERA P, Alexander T, Nallamothu BK
    India and the Coronary Stent Market: Getting the Price Right.
    Circulation. 2017 May 4. pii: CIRCULATIONAHA.117.028191.
    PubMed     Text format     Abstract available

  47. GOLDBERG RB, Aroda VR, Bluemke DA, Barrett-Connor E, et al
    Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium.
    Circulation. 2017 May 5. pii: CIRCULATIONAHA.116.025483.
    PubMed     Text format     Abstract available

  48. ZANNAD F, Rossignol P
    Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action.
    Circulation. 2017;135:1769-1771.
    PubMed     Text format    

  49. WEINTRAUB WS, Garratt KN
    Public Reporting II: State of the Art-Current Public Reporting in Cardiovascular Medicine.
    Circulation. 2017;135:1772-1774.
    PubMed     Text format    

  50. PURI R, Puri S, Rajani A
    Letter by Puri et al Regarding Article, "Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control".
    Circulation. 2017;135:e1039-e1040.
    PubMed     Text format    

  51. KESSLER T, Wobst J, Wolf B, Eckhold J, et al
    Functional Characterization of the GUCY1A3 Coronary Artery Disease Risk Locus.
    Circulation. 2017 May 9. pii: CIRCULATIONAHA.116.024152.
    PubMed     Text format     Abstract available


    Eur Heart J

  52. SCHUPKE S, Mehilli J
    Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    PubMed     Text format    


    Hypertension

  53. SARAFIDIS PA, Loutradis C, Karpetas A, Tzanis G, et al
    Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.
    Hypertension. 2017 May 8. pii: HYPERTENSIONAHA.117.09023.
    PubMed     Text format     Abstract available


    Int J Cardiol

  54. HERMANS MPJ, van der Velden D, Montero Cabezas JM, Putter H, et al
    Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies.
    Int J Cardiol. 2017 Apr 25. pii: S0167-5273(16)33904.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  55. ROVIO SP, Pahkala K, Nevalainen J, Juonala M, et al
    Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.
    J Am Coll Cardiol. 2017;69:2279-2289.
    PubMed     Text format     Abstract available

  56. LLOYD-JONES DM, Allen NB
    Childhood Cardiovascular Risk Factors and Midlife Cognitive Performance: Time to Act on Primordial Prevention.
    J Am Coll Cardiol. 2017;69:2290-2292.
    PubMed     Text format    

  57. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    PubMed     Text format     Abstract available

  58. NIEDERSEER D, Stadlmayr A, Huber-Schonauer U, Ploderl M, et al
    Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia.
    J Am Coll Cardiol. 2017;69:2348-2350.
    PubMed     Text format    

  59. MUNTNER P, Whelton PK
    Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
    J Am Coll Cardiol. 2017;69:2446-2456.
    PubMed     Text format     Abstract available

  60. MUNZEL T, Heusch G
    Chest Pain Unit Network in Germany: Its Effect on Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;69:2459-2460.
    PubMed     Text format    

  61. ALBAGHDADI M
    Global Cardiovascular Health: A Role for the Interventionalist.
    J Am Coll Cardiol. 2017;69:2461-2464.
    PubMed     Text format    

  62. BOKMA JP, Winter MM, Kuijpers JM, Jongbloed MR, et al
    Role of Acquired Cardiovascular Disease in Tetralogy of Fallot Patients >50 Years of Age.
    J Am Coll Cardiol. 2017;69:2465-2466.
    PubMed     Text format    

  63. STONE PH
    Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress.
    J Am Coll Cardiol. 2017;69:2314-2316.
    PubMed     Text format    

  64. ELIAS J, Hoebers LP, van Dongen IM, Claessen BEPM, et al
    Impact of Chronic Total Occlusion Location on LV Function in ST-Segment Elevation Myocardial Infarction Patients.
    J Am Coll Cardiol. 2017;69:2347-2348.
    PubMed     Text format    


    J Mol Cell Cardiol

  65. GANDA A, Yvan-Charvet L, Zhang Y, Lai EJ, et al
    Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
    J Mol Cell Cardiol. 2017 May 3. pii: S0022-2828(17)30089.
    PubMed     Text format     Abstract available


    Mayo Clin Proc

  66. FERDINAND KC, Nasser SA
    Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial Discrimination.
    Mayo Clin Proc. 2017;92:689-692.
    PubMed     Text format    

  67. DUNLAY SM, Lippmann SJ, Greiner MA, O'Brien EC, et al
    Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study.
    Mayo Clin Proc. 2017;92:699-709.
    PubMed     Text format     Abstract available

  68. EDWARDS MK, Addoh O, Loprinzi PD
    Predictive Validity of a Fitness Fatness Index in Predicting Cardiovascular Disease and All-Cause Mortality.
    Mayo Clin Proc. 2017;92:851.
    PubMed     Text format    


    Mol Cell Biochem

  69. SUMI S, Ramachandran S, RamanKutty V, Patel MM, et al
    ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus.
    Mol Cell Biochem. 2017 May 11. doi: 10.1007/s11010-017-3057.
    PubMed     Text format     Abstract available


    N Engl J Med

  70. DAWES TJ, Price S
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892-3.
    PubMed     Text format    

  71. MILOJEVIC M, Kappetein AP, Head SJ
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892.
    PubMed     Text format    

  72. MYLES PS, Smith JA, Painter T
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1893.
    PubMed     Text format    

  73. JIMENEZ-RIVERA JJ, Iribarren-Sarrias JL, Martinez-Sanz R
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891.
    PubMed     Text format    

  74. WANG DSH, Mazer CD, Orser BA
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891-2.
    PubMed     Text format    

  75. BHATT DL
    Assessment of Stable Coronary Lesions.
    N Engl J Med. 2017;376:1879-1881.
    PubMed     Text format    


    PLoS One

  76. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available

  77. TSUTSUMI J, Minai K, Kawai M, Ogawa K, et al
    Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor.
    PLoS One. 2017;12:e0177327.
    PubMed     Text format     Abstract available

  78. ENTIN-MEER M, Cohen L, Hertzberg-Bigelman E, Levy R, et al
    TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages.
    PLoS One. 2017;12:e0177132.
    PubMed     Text format     Abstract available

  79. ROJAS SV, Kensah G, Rotaermel A, Baraki H, et al
    Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    PLoS One. 2017;12:e0173222.
    PubMed     Text format     Abstract available

  80. MURINO RAFACHO BP, Portugal Dos Santos P, Goncalves AF, Fernandes AAH, et al
    Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
    PLoS One. 2017;12:e0177521.
    PubMed     Text format     Abstract available

  81. MORIMOTO T, Mineharu Y, Ono K, Nakatochi M, et al
    Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    PLoS One. 2017;12:e0175649.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: